Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Treasury Shares (2019 - 2022)

Historic Treasury Shares for Cue Biopharma (CUE) over the last 4 years, with Q2 2022 value amounting to $6667.0.

  • Cue Biopharma's Treasury Shares fell 9687.49% to $6667.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $6667.0, marking a year-over-year decrease of 9687.49%. This contributed to the annual value of $98335.0 for FY2021, which is 5724.6% down from last year.
  • According to the latest figures from Q2 2022, Cue Biopharma's Treasury Shares is $6667.0, which was down 9687.49% from $6667.0 recorded in Q1 2022.
  • In the past 5 years, Cue Biopharma's Treasury Shares registered a high of $263335.0 during Q3 2020, and its lowest value of $6667.0 during Q1 2022.
  • For the 4-year period, Cue Biopharma's Treasury Shares averaged around $160304.5, with its median value being $213336.0 (2021).
  • In the last 5 years, Cue Biopharma's Treasury Shares soared by 13000.2% in 2020 and then tumbled by 9687.49% in 2022.
  • Over the past 4 years, Cue Biopharma's Treasury Shares (Quarter) stood at $100000.0 in 2019, then soared by 130.0% to $230002.0 in 2020, then crashed by 57.25% to $98335.0 in 2021, then crashed by 93.22% to $6667.0 in 2022.
  • Its Treasury Shares was $6667.0 in Q2 2022, compared to $6667.0 in Q1 2022 and $98335.0 in Q4 2021.